BeInCrypto·
Goldman Sachs Says China Biotech Is Where Big Pharma Is Shopping Now
$440B
drugs losing patents
Goldman Sachs analyst Salveen Richter says big pharma is shopping in China biotech as $440 billion in drugs lose patents.
More news
- Bitcoin.com NewsXRP Could Skip Final Rally and Fall Toward $1.27 Support
- Crypto BriefingKraken co-CEO Arjun Sethi says the exchange has about 7 million funded accounts
- CryptoSlateSEC drops to 2 members, and 1 hidden rule shifts crypto power
- Crypto BriefingPenguin Solutions posts strong Q4 results, raises FY27 guidance
- Crypto BriefingBitcoin falls nearly $2,000 in 20 minutes as $400 million in longs get liquidated
- BeInCryptoAbstract's Shutdown Lifts the Pudgy Penguins NFT Floor but Weighs on Its Token